Rating Change
Guggenheim reiterated its Buy rating on Tenet Healthcare Corporation (NYSE:THC) on October 30, 2026.
reiterateNYSE:THC
Guggenheim Reiterates Buy Rating on Tenet Healthcare Corporation (THC)
Guggenheim reiterated its Buy rating on Tenet Healthcare Corporation (NYSE:THC) on October 30, 2026.
At publication ·
What changed
Tenet Healthcare Corporation (NYSE:THC) · reiterate
- Firm
- Guggenheim
- Rating
- Buy to Buy
- Price at event
- $271.07
- Market capitalization
- $17.4B
At a glance
Key takeaways
- Guggenheim reiterated a Buy rating on Tenet Healthcare (THC) on October 30, 2026, with the stock trading at $271.07 and a market cap of $17.4 billion.
Market Context
Tenet Healthcare Corporation operates in the Healthcare sector. The stock currently trades at $271.07 with a market capitalization of $17.4B. The stock has gained 29.7% over the past 52 weeks.
Analyst coverage from Guggenheim provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Tenet Healthcare Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Tenet Healthcare Corporation
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 30, 2026 | Guggenheim | Buy | N/A |
| Oct 16, 2026 | Guggenheim | Buy | N/A |
| Sep 23, 2026 | BMO Capital | Market Perform | N/A |
| Sep 18, 2026 | Leerink Partners | Outperform | N/A |
| Aug 03, 2026 | Wells Fargo | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View THC Stock Page
Frequently Asked Questions
What does the Buy rating mean for THC?
A rating of Buy from Guggenheim reflects the analyst's outlook on Tenet Healthcare Corporation (NYSE:THC). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the THC forecast page.